326117006: Dinoprostone 10mg/mL infusion concentrate 0.5mL ampule (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1763417011 Dinoprostone 10mg/mL infusion concentrate 0.5mL ampule (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1772616015 Dinoprostone 10mg/mL infusion concentrate 0.5mL ampoule en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1773931018 Dinoprostone 10mg/mL infusion concentrate 0.5mL ampule en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

323691000077115 dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion	Is a	Product containing dinoprostone in parenteral dose form (medicinal product form)	false	Inferred relationship	Some
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Prostaglandin PGE>2<	false	Inferred relationship	Some
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Prostaglandin E>1<	false	Inferred relationship	Some
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Dinoprostone (substance)	false	Inferred relationship	Some
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Posterior pituitary hormone	false	Inferred relationship	Some
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Alprostadil	false	Inferred relationship	Some
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion	Has manufactured dose form	injection	false	Inferred relationship	Some
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion	Has manufactured dose form	Infusion concentrate	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Concept inactivation indicator reference set

REPLACED BY association reference set (foundation metadata concept)